Literature DB >> 10767855

Cervical cytology after 2000: where to go?

C J Meijer1, J M Walboomers.   

Abstract

Mesh:

Year:  2000        PMID: 10767855      PMCID: PMC1731046          DOI: 10.1136/jcp.53.1.41

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  16 in total

1.  Assessment of automated primary screening on PAPNET of cervical smears in the PRISMATIC trial. PRISMATIC Project Management Team.

Authors: 
Journal:  Lancet       Date:  1999-04-24       Impact factor: 79.321

Review 2.  Detection of human papillomavirus in cervical scrapes by the polymerase chain reaction in relation to cytology: possible implications for cervical cancer screening.

Authors:  C J Meijer; A J van den Brule; P J Snijders; T Helmerhorst; P Kenemans; J M Walboomers
Journal:  IARC Sci Publ       Date:  1992

3.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

4.  A screening programme for cervical cancer that worked.

Authors:  M Hakama; K Louhivuori
Journal:  Cancer Surv       Date:  1988

5.  Human papillomavirus analysis as a prognostic marker following conization of the cervix uteri.

Authors:  K L Chua; A Hjerpe
Journal:  Gynecol Oncol       Date:  1997-07       Impact factor: 5.482

6.  PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears.

Authors:  L Rozendaal; J M Walboomers; J C van der Linden; F J Voorhorst; P Kenemans; T J Helmerhorst; M van Ballegooijen; C J Meijer
Journal:  Int J Cancer       Date:  1996-12-11       Impact factor: 7.396

7.  Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison.

Authors:  M V Jacobs; P J Snijders; F J Voorhorst; J Dillner; O Forslund; B Johansson; M von Knebel Doeberitz; C J Meijer; T Meyer; I Nindl; H Pfister; E Stockfleth; A Strand; G Wadell; J M Walboomers
Journal:  J Clin Pathol       Date:  1999-07       Impact factor: 3.411

8.  Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology.

Authors:  L J Bollen; S P Tjong-A-Hung; J van der Velden; B W Mol; F W ten Kate; J ter Schegget; O P Bleker
Journal:  Gynecol Oncol       Date:  1999-02       Impact factor: 5.482

9.  High cell kinetics is associated with amplification of the int-2, bcl-1, myc and erbB-2 proto-oncogenes and loss of heterozygosity at the DF3 locus in primary breast cancers.

Authors:  A Contegiacomo; C Pizzi; L De Marchis; M Alimandi; P Delrio; E Di Palma; G Petrella; L Ottini; D French; L Frati
Journal:  Int J Cancer       Date:  1995-03-29       Impact factor: 7.396

10.  Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens.

Authors:  K Elfgren; P Bistoletti; L Dillner; J M Walboomers; C J Meijer; J Dillner
Journal:  Am J Obstet Gynecol       Date:  1996-03       Impact factor: 8.661

View more
  6 in total

1.  Cervical cancer.

Authors:  P J van Diest; H Holzel
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

Review 2.  What we could do now: molecular pathology of gynaecological cancer.

Authors:  C S Herrington
Journal:  Mol Pathol       Date:  2001-08

Review 3.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

4.  Papillomavirus research update: highlights of the Barcelona HPV 2000 international papillomavirus conference.

Authors:  F X Bosch; T Rohan; A Schneider; I Frazer; H Pfister; X Castellsagué; S de Sanjosé; V Moreno; L M Puig-Tintore; P G Smith; N Muñoz; H zur Hausen
Journal:  J Clin Pathol       Date:  2001-03       Impact factor: 3.411

5.  Extended duration of the detectable stage by adding HPV test in cervical cancer screening.

Authors:  M E van den Akker-van Marie; M van Ballegooijen; L Rozendaal; C J L M Meijer; J D F Habbema
Journal:  Br J Cancer       Date:  2003-11-17       Impact factor: 7.640

Review 6.  A meta-analysis of the relationship between vaginal microecology, human papillomavirus infection and cervical intraepithelial neoplasia.

Authors:  Yuejuan Liang; Mengjie Chen; Lu Qin; Bing Wan; He Wang
Journal:  Infect Agent Cancer       Date:  2019-10-26       Impact factor: 2.965

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.